Sonja Pyott

Dr. Sonja Pyott

University Medical Center Groningen (UMCG), University of Groningen
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Cell
Verified
Journal Article
Closed access
JRJeong-Seop Rhee
Jeong-Seop Rhee
ABAndrea Betz
Andrea Betz
Sonja PyottSonja Pyott
Sonja Pyott
KRKerstin Reim
Kerstin Reim
FVFrederique Varoqueaux
Frederique Varoqueaux
NBNils Brose
Nils Brose


15 July 2000 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
TCT. L. Colliver
T. L. Colliver
Sonja PyottSonja Pyott
Sonja Pyott
MAM. Achalabun
M. Achalabun
AEAndrew G. Ewing
Andrew G. Ewing
It has been well established that the volume of secretory vesicles can be modulated. However, we present the first data demonstrating that the amount of transmitter in a vesicle can regulate its volume. Amperometry and transmission electron microscopy have been used to determine thatl-3,4-dihydroxyphenylalanine and reserpine increase and decrease, respectively, the volume of single pheochromocytoma cell vesicles as well as their catecholamine content. Because changes in vesicular catecholamine content are tracked by changes in vesicle volume, our results indicate that when quantal size is altered via the vesicular monoamine transporter the concentration of catecholamines within the vesicles remains relatively constant. This previously unidentified cellular response provides new insight into how catecholamines can be packaged in and released from secretory vesicles.

12 December 2008 in Journal of the Association for Research in Otolaryngology
Verified
Journal Article
Closed access
PDF file
WMWill J. McLean
Will J. McLean
KSK. Anne Smith
K. Anne Smith
EGElisabeth Glowatzki
Elisabeth Glowatzki
Sonja PyottSonja Pyott
Sonja Pyott

1 February 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Sonja PyottSonja Pyott
Sonja Pyott
AMAndrea L. Meredith
Andrea L. Meredith
AFAnthony A. Fodor
Anthony A. Fodor
AVAna E. Vázquez
Ana E. Vázquez
EYEbenezer N. Yamoah
Ebenezer N. Yamoah
RARichard W. Aldrich
Richard W. Aldrich
Large conductance voltage- and calcium-activated potassium (BK) channels are important for regulating many essential cellular functions, from neuronal action potential shape and firing rate to smooth muscle contractility. In amphibians, reptiles, and birds, BK channels mediate the intrinsic frequency tuning of the cochlear hair cell by an electrical resonance mechanism. In contrast, inner hair cells of the mammalian cochlea are extrinsically tuned by accessory structures of the cochlea. Nevertheless, BK channels are present in inner hair cells and encode a fast activating outward current. To understand the role of the BK channel alpha and beta subunits in mammalian inner hair cells, we analyzed the morphology, physiology, and function of these cells from mice lacking the BK channel alpha (Slo-/-) and also the beta1 and beta4 subunits (beta1/4-/-). Beta1/4-/- mice showed normal subcellular localization, developmental acquisition, and expression of BK channels. Beta1/4-/- mice showed normal cochlear function as indicated by normal auditory brainstem responses and distortion product otoacoustic emissions. Slo-/- mice also showed normal cochlear function despite the absence of the BKalpha subunit and the absence of fast activating outward current from the inner hair cells. Moreover, microarray analyses revealed no compensatory changes in transcripts encoding ion channels or transporters in the cochlea from Slo-/- mice. Slo-/- mice did, however, show increased resistance to noise-induced hearing loss. These findings reveal the fundamentally different contribution of BK channels to nonmammalian and mammalian hearing and suggest that BK channels should be considered a target in the prevention of noise-induced hearing loss.

1 June 2016 in Hearing Research
Verified
Journal Article
Open access
DRDaniël O.J. Reijntjes
Daniël O.J. Reijntjes
Sonja PyottSonja Pyott
Sonja Pyott
The spiral ganglion neurons (SGNs) are the first action potential generating neurons in the auditory pathway. The type I SGNs contact the sensory inner hair cells via their peripheral dendrites and relay auditory information to the brainstem via their central axon fibers. Individual afferent fibers show differences in response properties that are essential for normal hearing. The mechanisms that give rise to the heterogeneity of afferent responses are very poorly understood but are likely already in place at the peripheral dendrites where synapses are formed and action potentials are generated. To identify these molecular mechanisms, this review synthesizes a variety of literature and comprehensively outlines the cellular and molecular components positioned to regulate SGN afferent dendrite excitability, especially following glutamate release. These components include 1) proteins of the SGN postsynapses and neighboring supporting cells that together shape glutamatergic signaling, 2) the ion channels and transporters that determine the intrinsic excitability of the SGN afferent dendrites, and 3) the neurotransmitter receptors that extrinsically modify this excitability via synaptic input from the lateral olivocochlear efferents. This cellular and molecular machinery, together with presynaptic specializations of the inner hair cells, can be collectively referred to as the type I afferent signaling complex. As this review underscores, interactions of this signaling complex determine excitability of the SGN afferent dendrites and the afferent fiber responses. Moreover, this complex establishes the environmental milieu critical for the development and maintenance of the SGN afferent dendrites and synapses. Motivated by these important functions, this review also indicates areas of future research to elucidate the contributions of the afferent signaling complex to both normal hearing and also hearing loss.